The right stuff: execs with the Midas touch

August 31, 2006
Business Services, Research and Development biotech, management, recruitment

Here's a challenge: find someone with PhD-level scientific knowledge, a strong management track record and entrepreneurial flair. If there are …

GSK signs $1.5 billion drug discovery deal

August 31, 2006
Research and Development

GlaxoSmithKline has formed an alliance with Californian biotech company ChemoCentryx through its innovative drug development partnering unit.A licensing deal has …

MabThera shows promise in multiple sclerosis

August 29, 2006
Research and Development

The blockbuster non-Hodgkin's lymphoma treatment MabThera could offer a new treatment option for people with multiple sclerosis according to new …

Battle for Herceptin finally over

August 29, 2006

Newbury and Community PCT has lost its appeal against NICE's recommendation for cancer drug Herceptin, finally ending the battle over …

Business Intelligence Awards launched

August 23, 2006
Sales and Marketing BHBIA

The first ever awards for business intelligence and market research in the UK pharmaceutical industry have been launched to recognise …

Time to get back to our scientific basics

August 23, 2006
Research and Development biotech, drug safety, industry reputation

Recently I was wandering through the local market, and found myself in front of a stall selling therapeutic magnets. I …

New broom Kindler sweeps away Pfizer bureaucracy

August 21, 2006
Research and Development, Sales and Marketing

Pfizer's new chief executive Jeffery Kindler has unveiled changes to the company's senior management structure just days into his new …

Pfizer switches agencies in time for Sutent’s UK launch

August 18, 2006
Medical Communications Reynolds-Mackenzie, Sutent

 Pfizer has enlisted PR agency Reynolds-Mackenzie to support the UK launch and subsequent development of its potential blockbuster kidney cancer …

Head-to-head: Nice and the SMC

August 16, 2006
Research and Development, Sales and Marketing NICE, SMC, healthcare

The announcements on NHS budget deficits and the debates surrounding the prescribing of costly drugs, such as in the  Herceptin …

NICE gives breast cancer drugs the green light

August 15, 2006
Sales and Marketing

Aromatase inhibitors are to become more widely available for post-menopausal women with early breast cancer.As expected, NICE's final appraisal determination …

Vernalis takes diabetes pain drug into phase II

August 15, 2006
Research and Development Vernalis

UK biotech company Vernalis has started enrolment into a phase II trial of V3381, a drug designed for patients with …

Huge regional variations in NHS spending revealed

August 11, 2006

A new report has revealed large differences in how NHS money is spent across England, with some PCTs spending much …

NHS research could face

August 11, 2006
Research and Development

The British Medical Association is questioning the government over a possible 300 million pound drop in funding available for medical …

Empowering patients will cut medication errors, says watchdog

August 11, 2006
patients

An NHS watchdog has urged renewed efforts to cut the number of drug errors by improving prescribing and dispensing in …

Generic version of Plavix launched in US

August 10, 2006
Sales and Marketing

A generic company has launched a version of blood-thinning blockbuster product Plavix in the US, threatening the $3.3 billion sales …

GSK delivers strong quarterly performance

August 9, 2006
Sales and Marketing

GlaxoSmithKline's pharmaceutical sales rose by 10% in this year's second quarter earning the company a total of five billion pounds.Sales …

Lilly’s new products drive up sales

August 8, 2006
Sales and Marketing

Accelerated sales of predicted blockbuster depression treatment Cymbalta have helped boost Lilly sales for the second quarter of 2006.The drug …

Identifying and nurturing talent in your salesforce

August 7, 2006
Sales and Marketing Schering-Plough, UK, sales, strategy

The aim of every company, pharma or otherwise, is to boost sales and take a greater market share. However, despite …

Takeda selects London for new European business

August 4, 2006
Sales and Marketing

Japanese pharmaceutical company Takeda has chosen London as the site of its new four million pound European sales and marketing …

McKinnell makes early exit from Pfizer

August 3, 2006
Sales and Marketing Pfizer

Hank McKinnell has stepped down as chief executive of Pfizer earlier than expected following continued criticism of his performance from …

The Gateway to Local Adoption Series

Latest content